夢想之星の婕琳

Hello Brand Partners and Customers,

I'd like to give you some insight on our recent decision regarding the Vemma PM™ brand. Below is the official company statement we are sending to every Brand Partner and Customer who have purchased Vemma PM.

Many of our Brand Partners and Customers are reporting great results with Vemma PM. However, despite our warnings, we have learned that people are continuing to take prescription medications and OTC (over-the-counter) pain, cold and flu medications with Vemma PM. These drugs may interact with Vemma PM to cause liver issues (such as abdominal pain, high enzyme count, dark urine or jaundice). For example, you may not be aware, but just taking the maximum dosage of one of the USA's most popular pain-relievers for four days can cause your liver enzymes to elevate from 40 (normal) to over 600¹. If you are taking such medications with our product or are experiencing any such symptoms, please stop taking Vemma PM and your symptoms should subside. In addition, you should consult with your healthcare professional if you are experiencing these symptoms. The same applies with respect to alcohol. We have also learned that despite our warnings, people have been consuming alcoholic beverages along with Vemma PM. We cannot control what medications people take with Vemma PM or whether they consume alcohol with our product. In an abundance of caution, we have decided to stop selling the current version of Vemma PM as of Wednesday, February 23, 2011 and to reformulate the product. The new version will be formulated to minimize interactions between our product and medications and alcohol. We apologize for this inconvenience.

If you are building your Vemma business with a focus on Vemma PM, during this time period we encourage you to refocus your efforts on our other clinically studied products that have been proven to have mass appeal and extreme consumer loyalty. You represent the finest wellness brand available on the market and we hope you understand this decision. Please know that our legacy of responsibility, quality and consumer commitment remains our most important objective and we will uphold it. Thank you.

1. Watkins, et al. Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial. JAMA. 2006 Jul 5; 296(1):87-93.

Keep in mind, we don't want to do anyone a disservice and withhold a great product from someone who needs it, but we're a wellness company, not a drug company. We will get this challenge corrected and we'll be a better company for it. You hear companies give you the "people first" line all the time, but this issue brings our statement of "people before profits" to life and proves it's not just clever marketing copy. We're here to make a positive difference and this will be a chapter in Vemma's history where we'll need every leader to stand up for our brand and emphasize the point that this issue has a good side to it. It's proof of integrity, it's confirmation of a wellness philosophy that few companies ever get a chance to be tested on. Challenges will come and go in any business, but what remains are the actions taken to overcome them.

Opportunities are sometimes disguised as challenges and what we've learned from this challenge is that the Vemma PM brand will be a long-term, and immensely valuable addition to the Vemma line. The story and importance of sleep fits perfectly within our business model. This reformulation project will allow us greater market reach in two ways. First, by allowing a greater number of those people currently using OTC and prescription drugs the ability to enjoy PM. Second, by possibly allowing a greater number than seven out of ten people a positive response to the formula.

I was taught that everything happens for a reason. This one challenge/opportunity will prove itself to be in that category. Something great will come of it and you'll have a better understanding that your Home Office team makes its decisions based on the simple thought...do what's right and do it quickly.

At Vemma, we're long-term thinkers. In the short term, this decision may annoy some people who have discovered how great a good night's sleep feels, but in the long term, we'll look back at these next few months as one of the wisest decisions this company has made in a long time.

Thanks for all you do to take this Vemma mission to the people who need it.

BK Boreyko
Founder, CEO 

以下GOOGOLE翻譯:

您好品牌合作夥伴和客戶，

我想給你一些有識之士對我們最近決定關於 Vemma PM™品牌。以下是官方聲明，我們公司發送的每一個品牌的合作夥伴和客戶誰購買 Vemma PM。

我們的許多品牌的合作夥伴和客戶都報告了很大的成效與Vemma PM。然而，儘管我們警告，我們了解到，人們繼續採取處方藥和非處方藥（超過非處方）疼痛，感冒和流感的藥物與Vemma PM。這些藥物可能會與Vemma PM引起肝臟問題（如腹痛，高酶計數，深色尿或黃疸）。例如，你可能不知道，只是服用最大劑量的一個在美國最流行 ​​的疼痛藥四天可引起肝臟酶升高，從40（正常）超過600 ¹。如果你正在服用這種藥物與我們的產品或遇到任何症狀，請停止服用Vemma PM和你的症狀應該消退。此外，您應該諮詢您的醫療保健專業人士，如果您遇到這些症狀。這同樣適用於關於酒精。我們還了解到，儘管我們的警告，人們一直在飲用含酒精的飲料一起Vemma PM。我們無法控制藥物的人採取Vemma PM或是否飲酒與我們的產品。在一個豐富的謹慎，我們已經決定停止銷售當前版本的Vemma PM截至週三2月23日，2011年和改寫的產品。新版本將制定以減少我們的產品之間的相互作用和藥物和酒精。這個不便，我們深表歉意。

如果您正在構建您的Vemma業務，重點在Vemma下午，在這段時間內，我們鼓勵您重新聚焦於你的努力我們的其他產品的臨床研究已證實有群眾訴求和極端消費者的忠誠度。你們代表提供最好的健康品牌在市場上，我們希望你理解這個決定。請注意，我們遺留下來的責任，品質和消費者的承諾仍然是我們最重要的目標，我們將堅持它。謝謝。

1。沃特金斯，等。轉氨酶升高在接受健康成人每日4克對乙酰氨基酚：一項隨機對照試驗。 JAMA， 2006年7月5日; 296（1）:87 - 93。

請記住，我們不想做任何人造成損害，並保留一個偉大的產品的人誰需要它，但我們是一個健康的公司，而不是藥物的公司。我們將得到糾正這一挑戰，我們將是一個更好的公司它。你聽到公司給你的“以人為本”行所有的時間，但這個問題使我們的聲明“人前利潤”的生活，並證明它不只是聰明的營銷副本。我們在這裡做一個積極的變化，這將是一章中Vemma的歷史，我們需要每一個領導者要站起來為我們的品牌，並強調指出，這個問題有它好的一面。這證明完整性，這是確認一個健康的理念，很少有企業曾經有機會被測試。挑戰將出沒於任何業務，但仍然是採取的行動，以克服這些困難。

有時偽裝成機會的挑戰，我們已經了解到這個挑戰是，Vemma PM品牌將是一個長期的，和非常有價值的除了Vemma線。這個故事和重要性的睡眠完全合乎我們的商業模式。該項目將讓我們重新制定更大的市場覆蓋範圍在兩個方面。首先，允許更多的那些人目前使用非處方藥和處方藥的能力，享受PM。其次，可能允許更大數量超過七個十人積極響應公式。

我被教導說，一切發生的一個原因。這其中的挑戰 /機會將證明自己是這一類。一些偉大的事情會來的它，你將有一個更好的了解您的家庭辦公室的團隊使得其決策的基礎上，簡單的想法... ...做正確的事情，而且要快。

在Vemma，我們長期的思想家。從短期來看，這一決定可能會惹惱一些人誰發現多大的良好的睡眠的感覺，但是從長遠來看，我們將回顧一下這些未來幾個月為一體的最明智的決定，這家公司已在長的時間。

感謝你做藉此 Vemma使命的人誰需要它。

BK Boreyko
創始人，首席執行官